Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Obesity Reports

Open Access 04-03-2024 | Overweight | REVIEW

Behavioral Lifestyle Interventions for Weight Loss in Overweight or Obese Patients with Type 2 Diabetes: A Systematic Review of the Literature

Authors: Sara Gostoli, Giulia Raimondi, Alexandra Paula Popa, Micaela Giovannini, Giada Benasi, Chiara Rafanelli

Published in: Current Obesity Reports

Login to get access

Abstract

Purpose of Review

Around 80–90% of patients with type 2 diabetes mellitus (T2DM) are overweight or obese, presenting a greater risk for serious health complications and mortality. Thus, weight loss represents a main goal for T2DM management. Although behavioral lifestyle interventions (BLIs) could help promoting weight loss in T2DM patients with overweight or obesity, their effectiveness is still controversial. This systematic review offers an updated and comprehensive picture of BLIs according to Michie’s classification in T2DM patients with overweight or obesity and identifies possible factors (related to both patients and interventions) associated with weight loss. The PRISMA guidelines were followed. The literature search till March 2023 indicated 31 studies involving 42 different BLIs.

Recent Findings

Our findings suggest that structured BLIs, characterized by frequent feedback and support, can lead to a clinically meaningful 5% weight loss, regardless of specific behavioral, diet, and physical activity components.

Summary

Further research should address methodological issues and heterogeneity of interventions, also considering the effect of pharmacological therapies on weight reduction. Lastly, more attention should be paid to the long-term effectiveness of behavioral lifestyle interventions and to the relationship between weight loss and diabetes.
Appendix
Available only for authorised users
Literature
1.
2.
Koliaki C, Dalamaga M, Liatis S. Update on the obesity epidemic: after the sudden rise, is the upward trajectory beginning to flatten? Curr Obes Rep. 2023;12(4):514–27.PubMedPubMedCentralCrossRef
3.
4.
Nguyen NT, Nguyen XM, Lane J, Wang P. Relationship between obesity and diabetes in a US adult population: Findings from the National Health and Nutrition Examination Survey, 1999–2006. Obes Surg. 2011;21(3):351–5.PubMedCrossRef
5.
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2006;387(10027):15113–30.
6.
7.
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.PubMedCrossRef
8.
Nianogo RA, Arah OA. Forecasting obesity and type 2 diabetes incidence and burden: the ViLA-obesity simulation model. Front Public Health. 2022;10:818816.PubMedPubMedCentralCrossRef
9.
Boye KS, Ford JH, Thieu VT, Lage MJ, Terrell KA. The association between obesity and the 5-year prevalence of morbidity and mortality among adults with type 2 diabetes. Diabetes Ther. 2023;14(4):709–21.PubMedPubMedCentralCrossRef
10.
Franz MJ, Boucher JL, Rutten-Ramos S, VanWormer JJ. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. J Acad Nutr Diet. 2015;115(9):1447–63.PubMedCrossRef
11.
American Diabetes Association. 4. Lifestyle management: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(1):S38–50.CrossRef
12.
American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(1):S14–13.CrossRef
13.
Van Gaal LF, Mertens IL, Ballaux D. What is the relationship between risk factor reduction and degree of weight loss? Eur Heart J Suppl. 2005;7(L):L21–26.CrossRef
14.
Wing RR, Lang W, Wadden TA, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34(7):1481–6.PubMedPubMedCentralCrossRef
15.
Franz MJ, Bantle JP, Beebe CA, et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care. 2002;25(1):148–98.PubMedCrossRef
16.
Hilliard ME, Powell PW, Anderson BJ. Evidence-based behavioral interventions to promote diabetes management in children, adolescents, and families. Am Psychol. 2016;71(7):590–601.PubMedPubMedCentralCrossRef
17.
Amanat S, Ghahri S, Dianatinasab A, Fararouei M, Dianatinasab M. Exercise and type 2 diabetes. Adv Exp Med Biol. 2020;1228:91–105.PubMedCrossRef
18.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(1):S81–90.CrossRef
19.
Norris SL, Zhang X, Avenell A, et al. Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. Cochrane Database Syst Rev. 2005;(2):CD004095.PubMedPubMedCentral
20.
Ciliska D, Kelly C, Petrov N, Chalmers J. A review of the weight loss interventions for obese people with non-insulin-dependent diabetes mellitus. Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. 1995.
21.
Brown SA, Upchurch S, Anding R, Winter M, Ramìrez G. Promoting weight loss in type II diabetes. Diabetes Care. 1996;19(6):613–24.PubMedCrossRef
22.
Terranova CO, Brakenridge CL, Lawler SP, Eakin EG, Reeves MM. Effectiveness of lifestyle-based weight loss interventions for adults with type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab. 2015;17(4):371–8.PubMedCrossRef
23.
Cradock KA, ÓLaighin G, Finucane FM, Gainforth HL, Quinlan LR, Ginis KA. Behaviour change techniques targeting both diet and physical activity in type 2 diabetes: a systematic review and meta-analysis. Int J Behav Nutr Phys Act. 2017;14(1):18.PubMedPubMedCentralCrossRef
24.
Cradock KA, ÓLaighin G, Finucane FM, et al. Diet behavior change techniques in type 2 diabetes: A systematic review and meta-analysis. Diabetes Care. 2017;40(12):1800–10.PubMedCrossRef
25.
Curioni CC, Lourenço PM. Long-term weight loss after diet and exercise: a systematic review. Int J Obes. 2005;29(10):1168–74.CrossRef
26.
Katz DL. Competing dietary claims for weight loss: finding the forest through truculent trees. Annu Rev Public Health. 2005;26:61–88.PubMedCrossRef
27.
Michie S, Richardson M, Johnston M, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med. 2013;46(1):81–95.PubMedCrossRef
28.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group PRISMA. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.PubMedCrossRef
29.
Wang J, Cai C, Padhye N, Orlander P, Zare M. A behavioral lifestyle intervention enhanced with multiple-behavior self-monitoring using mobile and connected tools for underserved individuals with type 2 diabetes and comorbid overweight or obesity: pilot comparative effectiveness trial. JMIR mHealth uHealth. 2018;6(4):e4478.CrossRef
30.
Bentley CL, Otesile O, Bacigalupo R, et al. Feasibility study of portable technology for weight loss and HbA1c control in type 2 diabetes. BMC Med Inform Decis Mak. 2016;16:92.PubMedPubMedCentralCrossRef
31.
• Benasi G, Gostoli S, Zhu B, Offidani E, Artin MG, Gagliardi L, Rignanese G, Sassi G, Fava G, Rafanelli C. Well-Being Therapy and lifestyle intervention in type 2 diabetes: A pilot randomized controlled trial. Psychosom Med. 2022;84(9):1041–9. At post-treatment and 6-month follow-up, within-group analysis revealed that both Type 2 Diabetes Mellitus patients who underwent a sequential intervention based on Well-Being Therapy followed by Lifestyle Intervention and those who underwent Lifestyle Intervention alone, showed a statistically significant decrease in weight.PubMed
32.
Ziegler D, Strom A, Nowotny B, et al. Effect of low-energy diets differing in fiber, red meat, and coffee intake on cardiac autonomic function in obese individuals with type 2 diabetes. Diabetes Care. 2015;38(9):1750–7.PubMedCrossRef
33.
Delahanty LM, Dalton KM, Porneala B, Chang Y, Goldman VM, Levy D, Nathan DM, Wexler DJ. Improving diabetes outcomes through lifestyle change–a randomized controlled trial. Obesity. 2015;23(9):1792–9.PubMedCrossRef
34.
Delahanty LM, Chang Y, Levy DE, et al. Design and participant characteristics of a primary care adaptation of the Look AHEAD Lifestyle Intervention for weight loss in type 2 diabetes: the REAL HEALTH-diabetes study. Contemp Clin Trials. 2018;71:9–17.PubMedPubMedCentralCrossRef
35.
• St-Jules DE, Hu L, Woolf K, Wang C, Goldfarb DS, Katz SD, Popp C, Williams S, Li H, Jagannathan R, Ogedegbe O, Kharmats AY, Sevick MA. An evaluation of alternative technology-supported counseling approaches to promote multiple lifestyle behavior changes in patients with type 2 diabetes and chronic kidney disease. J Ren Nutr. 2023;33(1):35–44. Patients with Type 2 Diabetes Mellitus, who self-monitored their progress regarding weight loss using a preloaded application on a technological device, lost more weight in the first 3 months of the intervention compared to individuals who did not self-monitor their progress.PubMedCrossRef
36.
Lutes LD, Cummings DM, Littlewood K, Dinatale E, Hambidge B. A community health worker–delivered intervention in African American Women with type 2 diabetes: a 12-Month randomized trial. Obesity. 2017;25(8):1329–35.PubMedCrossRef
37.
Gallagher D, Heshka S, Kelley DE, Thornton J, Boxt L, Pi-Sunyer FX, Patricio J, Mancino J, Clark JM, MRI Ancillary Study Group of the Look AHEAD Research Group. Changes in adipose tissue depots and metabolic markers following a 1-year diet and exercise intervention in overweight and obese patients with type 2 diabetes. Diabetes Care. 2014;37(12):3325–32.PubMedPubMedCentralCrossRef
38.
West DS, Dutton G, Delahanty LM, Hazuda HP, Rickman AD, Knowler WC, Vitolins MZ, Neiberg RH, Peters A, Gee M, Begay MC, Look AHEAD Research Group. Weight loss experiences of African American, Hispanic, and Non-Hispanic White men and women with type 2 diabetes: The Look AHEAD Trial. Obesity. 2019;27(8):1275–84.PubMedCrossRef
39.
Look AHEAD Research Group. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2014;2(10):801–9.CrossRef
40.
Rejeski WJ, Bray GA, Chen SH, Clark JM, Evans M, Hill JO, Jakici JM, Johnson KC, Neiberg R, Ip EH, Look AHEAD Research Group. Aging and physical function in type 2 diabetes: 8 years of an intensive lifestyle intervention. J Gerontol - Biol Sci Med Sci. 2015;70(3):345–53.CrossRef
41.
Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity. 2014;22(1):5–13.CrossRef
42.
Action for Health in Diabetes (Look AHEAD) Study Group. Association of weight loss maintenance and weight regain on 4-year changes in CVD risk factors: The action for health in diabetes (look AHEAD) clinical trial. Diabetes Care. 2016;39(8):1345–55.CrossRef
43.
Gregg EW, Look AHEAD Study Group. Association of the magnitude of weight loss and physical fitness change on long-term CVD outcomes: The look AHEAD study. Lancet Diabetes Endocrinol. 2016;4(11):913–21.PubMedPubMedCentralCrossRef
44.
•• Look AHEAD Research Group. Effects of intensive lifestyle intervention on all-cause mortality in older adults with type 2 diabetes and overweight/obesity: results from the look AHEAD study. Diabetes Care. 2022;45(5):1252–9. Compared to Diabetes Support and Education (DSE) program, Intensive Lifestyle Intervention (ILI) led to a significantly greater amount of weight loss in more than 5000 patients with Type 2 Diabetes Mellitus. Moreover, among ILI patients, those who lost ≥10% of their body weight during the first year of the intervention, showed a reduced risk of mortality compared to DSE patients.PubMedCentralCrossRef
45.
Look AHEAD Research Group. Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial. Diabetes Care. 2014;37(6):1544–53.CrossRef
46.
Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145–54.CrossRef
47.
Moncrieft AE, Llabre MM, McCalla JR, Gutt M, Mendez AJ, Gellman MD, Goldberg R, Schneiderman N. Effects of a multicomponent life-style intervention on weight, glycemic control, depressive symptoms, and renal function in low-income, minority patients with type 2 diabetes: results of the community approach to lifestyle modification for diabetes randomized controlled trial. Psychosom Med. 2016;78(7):851–60.PubMedPubMedCentralCrossRef
48.
Kuna ST, Reboussin DM, Borradaile KE, Sanders MH, Millman RP, Zammit G, Newman AB, Wadden TA, Jakicic Jm, Wing RR, Pi-Sunyer FX, Foster GD, Sleep AHEAD Research Group of the Look AHEAD Research Group. Long-term effect of weight loss on obstructive sleep apnea severity in obese patients with type 2 diabetes. Sleep. 2013;36(5):641–9.PubMedPubMedCentralCrossRef
49.
Foster GD, Wadden TA, Lagrotte CA, Vander Veur SS, Hesson LA, Homko CJ, Maschak-Carey BJ, Barbor NR, Bailer B, Diewald L, Komaroff E, Herring SJ, Vetter ML. A randomized comparison of a commercially available portion-controlled weight-loss intervention with a diabetes self-management education program. Nutr Diabetes. 2013;3(3):e63.PubMedPubMedCentralCrossRef
50.
•• Delahanty LM, Levy DE, Chang Y, et al. Effectiveness of lifestyle intervention for type 2 diabetes in primary care: The real health-diabetes randomized clinical trial. J Gen Intern Med. 2020;35(9):2637–46. Lifestyle intervention delivered in-person or through telephone lead to weight loss in primary care patients with Type 2 Diabetes Mellitus at a reasonable cost.PubMedPubMedCentralCrossRef
51.
Gamiochipi M, Cruz M, Kumate J, Wacher NH, DIMSS Study Group. Effect of an intensive metabolic control lifestyle intervention in type-2 diabetes patients. Patient Educ Couns. 2016;99(7):1184–9.PubMedCrossRef
52.
Osama AJ, Shehab A. Psychological wellbeing and biochemical modulation in response to weight loss in obese type 2 diabetes patients. Afr Health Sci. 2015;15(2):503–12.PubMedPubMedCentralCrossRef
53.
Carter S, Clifton PM, Keogh JB. The effect of intermittent compared with continuous energy restriction on glycaemic control in patients with type 2 diabetes: 24-month follow-up of a randomised noninferiority trial. Diabetes Res Clin Pr. 2019;151:11–9.CrossRef
54.
Watson N, Dyer K, Buckley J, Brinkworth G, Coates A, Parfitt G, Howe P, Noakes M, Murphy K. Effects of low-fat diets differing in protein and carbohydrate content on cardiometabolic risk factors during weight loss and weight maintenance in obese adults with type 2 diabetes. Nutrients. 2016;8(5):289.PubMedPubMedCentralCrossRef
55.
Otten J, Stomby A, Waling M, Isaksson A, Söderström I, Ryberg M, Svensson M, Hauksson J, Olsson T. A heterogeneous response of liver and skeletal muscle fat to the combination of a Paleolithic diet and exercise in obese individuals with type 2 diabetes: a randomised controlled trial. Diabetologia. 2018;61:1548–59.PubMedPubMedCentralCrossRef
56.
Otten J, Stomby A, Waling M, Isaksson A, Tellström A, Lundin-Olsson L, Brage S, Ryberg M, Svensson M, Olsson T. Benefits of a Paleolithic diet with and without supervised exercise on fat mass, insulin sensitivity, and glycemic control: a randomized controlled trial in individuals with type 2 diabetes. Diabetes Metab Res Rev. 2017;33(1):e2828.CrossRef
57.
Goday A, Bellido D, Sajoux I, Crujeiras AB, Burguera B, García-Luna PP, Oleaga A, Moreno B, Casanueva FF. Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus. Nutr Diabetes. 2016;6(9):e230.PubMedPubMedCentralCrossRef
58.
•• Stomby A, Otten J, Ryberg M, Andrew R, Walker BR, Olsson T. Diet-induced weight loss alters hepatic glucocorticoid metabolism in type 2 diabetes mellitus. Eur J Endocrinol. 2020;182(4):447–57. Paleolithic-type diet, with or without physical exercise, was effective in promoting weight loss and reducing insulin sensitivity.PubMedPubMedCentralCrossRef
59.
Hankonen N, Sutton S, Prevost AT, Simmons RK, Griffin SJ, Kinmonth AL, Hardeman W. Which behavior change techniques are associated with changes in physical activity, diet and body mass index in people with recently diagnosed diabetes? Ann Behav Med. 2015;49(1):7–17.PubMedCrossRef
60.
Mellberg C, Sandberg S, Ryberg M, Eriksson M, Brage S, Larsson C, Olsson T, Lindahl B. Long-term effects of a Palaeolithic-type diet in obese postmenopausal women: A 2-year randomized trial. Eur J Clin Nutr. 2014;68(3):350–7.PubMedPubMedCentralCrossRef
61.
Stefan N, Fritsche A, Weikert C, Boeing H, JoostH-G Häring H-U, Schulze MB. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes. 2008;57(10):2762–7.PubMedPubMedCentralCrossRef
62.
Martenstyn J, King M, Rutherford C. Impact of weight loss interventions on patient-reported outcomes in overweight and obese adults with type 2 diabetes: A systematic review. J Behav Med. 2020;43(6):873–91.PubMedCrossRef
63.
Shaw K, O’Rourke P, Del Mar C, Kenardy J. Psychological interventions for overweight or obesity. Cochrane Database Syst Rev. 2005;2:CD003818.
64.
Maula A, Kai J, Woolley AK, et al. Educational weight loss interventions in obese and overweight adults with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Diabet Med. 2020;37(4):623–35.PubMedCrossRef
65.
Cai H, Li G, Zhang P, Xu D, Chen L. Effect of exercise on the quality of life in type 2 diabetes mellitus: a systematic review. Qual Life Res. 2017;26(3):515–30.PubMedCrossRef
66.
Cai X, Qiu SH, Yin H, et al. Pedometer intervention and weight loss in overweight and obese adults with type 2 diabetes: A meta-analysis. Diabet Med. 2016;33(8):1035–44.PubMedPubMedCentralCrossRef
67.
de Groot M, Doyle T, Kushnick M, Shubrook J, Merrill J, Rabideau E, Schwartz F. Can lifestyle interventions do more than reduce diabetes risk? Treating depression in adults with type 2 diabetes with exercise and cognitive behavioral therapy. Curr Diabetes Rep. 2012;12:157–66.CrossRef
68.
69.
Argyrakopoulou G, Fountouli N, Dalamaga M, Kokkinos A. Revisiting resting metabolic rate: what is the relation to weight fluctuations? Curr Obes Rep. 2023;12(4):502–13.PubMedCrossRef
70.
Clemente-Suárez VJ, Redondo-Flórez L, Beltrán-Velasco AI, Martín-Rodríguez A, Martínez-Guardado I, Navarro-Jiménez E, Laborde-Cárdenas CC, Tornero-Aguilera JF. The role of adipokines in health and disease. Biomedicines. 2023;11(5):1290.PubMedPubMedCentralCrossRef
71.
Pestel J, Blangero F, Watson J, Pirola L, Eljaafari A. Adipokines in obesity and metabolic-related-diseases. Biochimie. 2023;212:48–59.PubMedCrossRef
72.
Koliaki C, Liatis S, Dalamaga M, Kokkinos A. The implication of gut hormones in the regulation of energy homeostasis and their role in the pathophysiology of obesity. Curr Obes Rep. 2020;9(3):255–71.PubMedCrossRef
73.
Renjilian DA, Perri MG, Nezu AM, McKelvey WF, Shermer RL, Anton SD. Individual versus group therapy for obesity: effects of matching participants to their treatment preferences. J Consult Clin Psychol. 2001;69(4):717–21.PubMedCrossRef
74.
Jeffery RW, Gillum R, Gerber WM, Jacobs D, Elmer PJ, Prineas RJ. Weight and sodium reduction for the prevention of hypertension: a comparison of group treatment and individual counseling. Am J Public Health. 1983;73(6):691–3.PubMedPubMedCentralCrossRef
75.
Robertson C, Avenell A, Boachie C, Stewart F, Archibald D, Douglas F, Hoddinott P, van Teijlingen E, Boyers D. Should weight loss and maintenance programmes be designed differently for men? A systematic review of long-term randomised controlled trials presenting data for men and women: the ROMEO project. Obes Res Clin Pract. 2016;10(1):70–84.PubMedCrossRef
76.
77.
Stefan N, Häring HU. Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans. Nat Med. 2013;19(4):394–5.PubMedCrossRef
78.
Dong JY, Zhang ZL, Wang PY, Qin LQ. Effects of high-protein diets on body weight, glycaemic control, blood lipids and blood pressure in type 2 diabetes: meta-analysis of randomised controlled trials. Brit J Nutr. 2013;110(5):781–9.PubMedCrossRef
79.
Albosta M, Bakke J. Intermittent fasting: is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians. Clin Diabetes Endocrinol. 2021;7(1):1–12.CrossRef
Metadata
Title
Behavioral Lifestyle Interventions for Weight Loss in Overweight or Obese Patients with Type 2 Diabetes: A Systematic Review of the Literature
Authors
Sara Gostoli
Giulia Raimondi
Alexandra Paula Popa
Micaela Giovannini
Giada Benasi
Chiara Rafanelli
Publication date
04-03-2024
Publisher
Springer US
Published in
Current Obesity Reports
Electronic ISSN: 2162-4968
DOI
https://doi.org/10.1007/s13679-024-00552-5
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits